Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers

American Journal of Cardiology

Volumn 91, Issue 12, 2003, Pages 1510-1513

  Gardner, Stephanie F ^a   Franks, Amy M ^b   Gurley, Bill J ^b   Haller, Christine A ^b   Singh, Bal Krishna ^b   Mehta, Jawahar L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CONTROLLED STUDY; DIET SUPPLEMENTATION; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPHEDRA; HEART RATE; HEMOSTASIS; HOLTER MONITORING; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PHYSICAL EXAMINATION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0037864013     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00413-2     Document Type: Article

References (15)

1. Josefson D. Herbal stimulant causes U.S deaths. BMJ. 312:1996;1378-1379.
2. Haller C.A., Benowitz N.L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 343:2000;1833-1838.
3. Nightingale SL. Warning issued about street drugs containing botanical sources of ephedrine. JAMA 1996;275:1534.
4. Ault A. FDA proposes limits on ephedrine supplements. Lancet. 349:1997;1753.
5. Nadir A., Agarawal S., King P.D., Marshall J.B. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol. 91:1996;1436-1438.
6. Samenuk D., Link M.S., Houmoud M.K., Contreras R., Theohardes T.C., Wang P.J., Estes N.A.M. III. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc. 77:2002;12-16.
7. Rezkalla S.H., Mesa J., Sharma P., Kloner R.A. Myocardial infarction temporally related to ephedra - a possible role for the coronary microcirculation. Wisc Med J. 101:2002;64-66.
8. Morgenstern L.B., Viscoli C.M., Kernen W.N., Brass L.M., Broderick J.P., Feldmann E., Wilterdink J.L., Brott T., Horwitz R.I. Use of ephedra-containing products and risk for hemmorhagic stroke. Neurology. 60:2003;132-135.
9. Gurley B.J., Wang P., Gardner S.F. Ephedrine-type alkaloid content of nutritional supplements containing ephedra sinica (ma huang) as determined by high performance liquid chromatography. J Pharm Sci. 87:1998;1547-1553.
10. Haller C.A., Jacob P., Benowitz N.L. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 71:2002;421-432.
11. Mehta J.L., Li D.Y., Yang H., Raizada M.K. Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells. J Cardiovasc Pharmacol. 39:2002;789-794.
12. Onuigbo M, Alikhan M. Over-the-counter sympathomimetics: a risk factor for cardiac arrhythmias in pregnancy. South Med J 1998;91:1153-1155.
13. Zahn K.A., Li R.L., Purssell R.A. Cardiovascular toxicity after ingestion of "herbal ecstasy" J Emerg Med. 17:1999;289-291.
14. Boozer C.N., Nasser J.A., Heymsfield S.B., Wang V., Chen G., Solomon J.L. An herbal supplement containing ma huang-guarana for weight loss a randomized, double-blind trial . Int J Obes. 25:2001;316-324.
15. Norred C.L., Brinker F. Potential coagulation effects of preoperative complementary and alternative medicines. Altern Ther Health Med. 7:2001;58-67.